News

Most chronic kidney disease (CKD) stage 5 patients will develop high phosphorus levels in the blood known as hyperphosphatemia. Without effective treatment, hyperphosphatemia may lead to renal osteodystrophy,

The drug was powerful in its own right, the researchers say, but they found that some acute myeloid (AML) cells were themselves resistant to ABT-737, so they added

The acquisition of Conor Medsystems will provide Cordis Corporation, a subsidiary of Johnson & Johnson with the cardiovascular treatment CoStar Stent System. The CoStar Stent is currently sold

This submission for European Union approval was made in 2005 by the UK biopharmaceuticals company NeuTec Pharma, which Novartis acquired in mid-2006 to expand its portfolio of compounds

In the trial Onconase improved the efficacy of radiation therapy, resulting in significantly greater delay in tumor growth. Additionally, Onconase significantly induced apoptosis (programmed cell death) when administered

It is designed to assess the hypnotic efficacy of EVT 201 during seven nights’ treatment and also to determine the effect of improved sleep quality on daytime performance.

The study demonstrated a statistically significant achievement of all the primary and secondary endpoints. Patients receiving ferumoxytol had a significantly greater mean increase in hemoglobin compared to patients

The scientific team found that beta-agonists, such as those used in the treatment of asthma, increase the accumulation of type 2 T cells, a type of white blood

The clinical study is designed to evaluate the safety and pharmacokinetics of NorLevo in healthy Japanese adult female volunteers. NorLevo is an oral emergency contraceptive “morning after pill”